Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

NCT00099216 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

708

Enrollment

INDUSTRY

Sponsor class

Conditions

Vascular Dementia

Interventions

DRUG: Rivastigmine

Sponsor

Novartis Pharmaceuticals